$203 BillionThe market capitalization is the market value of the company. It is the sum of the value of all outstanding shares.
$77.26 - $118.28The lowest and highst price in the last 52 weeks.
39.88xThe price-earnings ratio is the ratio between the price per share (stock price) and the earnings per share. It indicates the percentage of the price per share (stock price) that is generated in earnings in the last 12 months.
$4.87 (4.24%)Dividends per share is the amount of dividends paid out to the shareholder of a single share in the last 12 months. The percentage indicates the ratio of the company's annual dividend compared to its current price per share (stock price).
|Market Cap||$203 Billion|
|Enterprise Value||$279 Billion|
|Dividend Yield||$4.87 (4.24%)|
|1 Year Return||+30.3%|
|Outstanding Shares||1.77 Billion|
|Avg 30 Day Volume||6.57 Million|
|Earnings per Share||$2.92|
|Price to Sales Ratio||4.1|
|Price to Book Ratio||16.39|
|Revenue to Enterprise Value||5.55|
|EBIT to Enterprise Value||21.22|
|Total Debt to Enterprise Value||0.31|
|Debt to Equity||6.24|
|Gross Profit||$32.5 Billion|
|Net Income||$5.09 Billion|
|Quarterly Earnings Growth (YoY)||+17.8%|
|Return on Equity||37.12%|
|Return on Assets||3.38%|
|Return on Invested Capital||11.08%|
The crown jewel of AbbVie's big-dollar acquisition of Allergan, Botox is one of the most recognizable brands in pharma — and both drugmakers have worked overtime to protect its advantage. After sco...Endpoints News, 4 months ago
DUBLIN--(BUSINESS WIRE)--The "Global Uveitis treatment Market 2020-2026" report has been added to ResearchAndMarkets.com's offering. The global uveitis treatment market is projected to witness cons...Business Wire, 4 months ago
AbbVie (NYSE: ABBV) shares weakened last week by more than 3%, and the current price stands around $104. According to analysts, it’s not hard to find reasons to invest in AbbVie, and as long the pr...Invezz, 4 months ago